Related Experiment Video
Updated: Jun 14, 2025

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Biological function of Aβ peptides revealed by analysis of membrane-association properties: Implications for
Meewhi Kim1, Ilya Bezprozvanny2
1Dept of Physiology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.
Abstract:
Proteolytic processing of amyloid precursor protein (APP) plays a critical role in the pathogenesis of Azheimer's disease (AD). Sequential cleavage of APP by β and γ secretases leads to generation of Aβ40 (non-amyloidogenic) and Aβ42 (amyloidogenic) peptides. Despite intense studies, the biological function of these peptides and the mechanism of Aβ42 toxicity is poorly understood. In the previous publications we proposed that association of Aβ peptides with the endosomal membranes may have important implications for pathogenesis of AD (Kim and Bezprozvanny, IJMS, 2021, vol 22, 13600; Kim and Bezprozvanny, IJMS, 2023, vol 24, 2092). To understand potential biological importance of such interaction, we focused on the region of Aβ peptides involved in peri-membrane association (E682 to N698). We discovered that association of this region with the membranes is reminiscent of several known anti-microbial peptides (AMP) such as PA13, Aurein1.2 and BP100. Our analysis further revealed that energy of peri-membrane association of Aβ40 is significantly weaker than for Aβ42 or AMP peptides, but it can be increased in the presence of non-amyloidogenic FAD mutations or in the presence of cholesterol in the membrane. Based on similarity with established mechanism of action of AMP peptides, we propose that Aβ peptides affect the curvature of endosomal membranes and shift the balance between endosomal recycling to plasma membrane and late endosomal/lysosomal pathway. We further propose that these effects are enhanced as a result of non-amyloidogenic FAD mutations in the sequence of Aβ peptides or in the presence of cholesterol in the membrane. The proposed model provides potential mechanistic explanation to synaptic defects induced by increased levels of Aβ42, by non-amyloidogenic FAD mutations in APP and by age-related increase in the levels of cholesterol in the brain.
Insights
Amyloid beta peptides, implicated in Alzheimer's disease (AD), interact with cell membranes. This interaction, similar to antimicrobial peptides, may explain synaptic defects linked to Aβ42, FAD mutations, and cholesterol.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Amyloid precursor protein (APP) processing is central to Alzheimer's disease (AD) pathogenesis.
- Cleavage of APP by β and γ secretases produces Aβ40 and Aβ42 peptides, with Aβ42 linked to toxicity.
- The biological roles and toxicity mechanisms of Aβ peptides remain incompletely understood.
Purpose of the Study:
- To investigate the biological significance of Aβ peptide association with endosomal membranes.
- To characterize the membrane-associating region (E682-N698) of Aβ peptides.
- To explore how FAD mutations and cholesterol influence Aβ-membrane interactions.
Main Methods:
- Comparative analysis of Aβ peptide membrane association with known antimicrobial peptides (AMPs).
- Assessment of peri-membrane association energy for Aβ40 and Aβ42.
- Evaluation of the impact of FAD mutations and cholesterol on Aβ-membrane binding.
Main Results:
- The Aβ peptide region E682-N698 exhibits membrane association similar to AMPs.
- Aβ40 shows weaker membrane association than Aβ42 or AMPs.
- Membrane association of Aβ peptides is enhanced by FAD mutations and cholesterol.
Conclusions:
- Aβ peptides may alter endosomal membrane curvature, influencing endosomal trafficking pathways.
- This mechanism, enhanced by FAD mutations or cholesterol, offers a potential explanation for synaptic defects in AD.
- The findings provide a mechanistic link between Aβ42, FAD mutations, cholesterol, and AD-related synaptic dysfunction.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...

